A Picture of Clinical Trial Supply Asia




Download Your Copy

We respect your privacy, by submitting this form you agree to having your details passed onto the sponsor who may promote similar products and services related to your area of interest. For further information on how we process and monitor your personal data click here.

In a recent survey published by Pharma IQ, we learnt that 62% of repsondents think China and India hold the most potential for clinical trials in the next 5 years. This along with the result,  that over 70% believe they will be outsourcing some element of clinical trials to the BRIC region in the next year, demonsatrate  that we can expect much growth in Clinical Trials in Asia in the coming future

 

[inlinead]

TO READ THE FULL STORY